Related Experiment Video
Updated: May 15, 2026
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Design considerations for targeted optical contrast agents
Jeong Heon Lee1, Gwangli Park, Gloria H Hong
1Division of Hematology/Oncology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, USA; ; Center for Molecular Imaging, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.
Abstract:
Optical fluorescence imaging with the right combination of imaging modality and targeted contrast agents offers tremendous improvement in intraoperative imaging and clinical output (i.e., image-guided cancer surgery). Therefore, it is of paramount importance to gain an in-depth knowledge in the design of targeted contrast agents to meet clinical requirements. Currently, there are several clinically approved contrast agents available; however, none perform optimally in vivo by providing optimum sensitivity, stability, specificity, and safety for target imaging, diagnosis, and therapy. In this review, we discuss basic design considerations for targeted contrast agents in terms of optical and physicochemical properties, biological and physiological interactions, and biodistribution and targeting.
Insights
Developing optimal targeted contrast agents is crucial for improving image-guided cancer surgery. This review discusses key design considerations for these agents to enhance in vivo performance for better diagnosis and therapy.
Area of Science:
- Biomedical Optics
- Nanotechnology
- Medical Imaging
Background:
- Optical fluorescence imaging enhances intraoperative guidance, particularly in cancer surgery.
- Current contrast agents lack optimal in vivo sensitivity, stability, specificity, and safety.
- Advanced targeted contrast agents are needed to meet clinical demands.
Purpose of the Study:
- To review fundamental design principles for targeted optical contrast agents.
- To address limitations of existing contrast agents for clinical applications.
- To guide the development of improved agents for enhanced cancer surgery.
Main Methods:
- Discussion of optical properties relevant to fluorescence imaging.
- Analysis of physicochemical characteristics influencing agent performance.
- Review of biological interactions, biodistribution, and targeting strategies.
Main Results:
- Identified critical factors in contrast agent design for optimal in vivo performance.
- Highlighted the need for balancing multiple properties (optical, physicochemical, biological).
- Emphasized the importance of tailored design for specific clinical needs.
Conclusions:
- Optimizing targeted contrast agent design is essential for advancing image-guided cancer surgery.
- Further research into agent properties can lead to improved diagnostic and therapeutic outcomes.
- A comprehensive understanding of design considerations is key to developing next-generation contrast agents.
More Related Videos
13:21Preparation, Purification, and Characterization of Lanthanide Complexes for Use as Contrast Agents for Magnetic Resonance Imaging
Published on: July 21, 2011
10:47Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
Published on: February 3, 2015
Related Concept Videos
01:24Modified-Release Drug Delivery Systems: Site-Targeted
01:26Phase Contrast and Differential Interference Contrast Microscopy
In-phase-contrast microscopes, interference between light directly passing through a cell and light refracted by cellular components is used to create high-contrast, high-resolution images without staining. It is the oldest and simplest type of microscope that creates an image by altering the wavelengths of light rays passing through the specimen. Altered wavelength paths are created using an annular stop in the condenser. The annular stop produces a hollow cone of...
02:24Properties of Enantiomers and Optical Activity